Key result
Co-expression of two cardiomyopathy mutant alleles additively slowed myocyte relaxation, whereas combining an activating and a deactivating mutant produced a hybrid phenotype that neutralized the primary defects.
Co-expression of double cardiomyopathy mutant alleles in rat myocytes demonstrates additive or neutralizing effects on contractile physiology, providing a cellular model for understanding disease severity in compound heterozygous patients.
Cautions against changing genetic counseling or therapy in cardiomyopathy patients; leaves open whether allele interactions determine human disease severity.
Inherited cardiomyopathy (CM) represents a diverse group of cardiac muscle diseases that present with a broad spectrum of symptoms ranging from benign to highly malignant. Contributing to this genetic complexity and clinical heterogeneity is the emergence of a cohort of patients that are double or compound heterozygotes who have inherited two different CM mutant alleles in the same or different sarcomeric gene. These patients typically have early disease onset with worse clinical outcomes. Little experimental attention has been directed towards elucidating the physiologic basis of double CM mutations at the cellular-molecular level. Here, dual gene transfer to isolated adult rat cardiac myocytes was used to determine the primary effects of co-expressing two different CM-linked mutant proteins on intact cardiac myocyte contractile physiology. Dual expression of two CM mutants, that alone moderately increase myofilament activation, tropomyosin mutant A63V and cardiac troponin mutant R146G, were shown to additively slow myocyte relaxation beyond either mutant studied in isolation. These results were qualitatively similar to a combination of moderate and strong activating CM mutant alleles alphaTmA63V and cTnI R193H, which approached a functional threshold. Interestingly, a combination of a CM myofilament deactivating mutant, troponin C G159D, together with an activating mutant, cTnIR193H, produced a hybrid phenotype that blunted the strong activating phenotype of cTnIR193H alone. This is evidence of neutralizing effects of activating/deactivating mutant alleles in combination. Taken together, this combinatorial mutant allele functional analysis lends molecular insight into disease severity and forms the foundation for a predictive model to deconstruct the myriad of possible CM double mutations in presenting patients.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2010) studied Cardiomyopathy. Dual gene transfer of cardiomyopathy mutant alleles vs. Single mutant gene transfer and wild type myocytes was evaluated on Myocyte relaxation time (75% relaxation time). Co-expression of two cardiomyopathy mutant alleles additively slowed myocyte relaxation, whereas combining an activating and a deactivating mutant produced a hybrid phenotype that neutralized the primary defects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: